EISAI CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,649 JPY | -3.25% |
|
-2.49% | -5.71% |
| 09:01am | Japan's Nikkei gains on chip shares boost; Fed policy in focus | RE |
| 05:20am | Japan's Nikkei rises on US stocks, heavyweight chip shares | RE |
| Sales 2024 | 742B 4.72B | Sales 2025 * | 766B 4.87B | Capitalization | 1,903B 12.11B |
|---|---|---|---|---|---|
| Net income 2024 | 42.41B 270M | Net income 2025 * | 48.21B 307M | EV / Sales 2024 | 2.21 x |
| Net cash position 2024 | 145B 924M | Net cash position 2025 * | 202B 1.28B | EV / Sales 2025 * | 2.22 x |
| P/E ratio 2024 |
42
x | P/E ratio 2025 * |
40.9
x | Employees | 11,076 |
| Yield 2024 |
2.57% | Yield 2025 * |
2.33% | Free-Float | 93.84% |
More Fundamentals
* Assessed data
More news
Latest transcript on Eisai Co., Ltd.
More recommendations
More press releases
More news
| 1 day | -3.25% | ||
| 1 week | -4.54% | ||
| Current month | -1.54% | ||
| 1 month | -1.70% | ||
| 3 months | +4.35% | ||
| 6 months | -12.15% | ||
| Current year | -5.71% |
1 week
6 529.00
7 110.00
1 month
6 432.007 110.00
Current year
5 795.007 818.00
1 year
5 795.0011 250.00
3 years
5 011.0012 765.00
5 years
5 011.0012 765.00
10 years
4 064.0012 765.00
| Managers | Title | Age | Since |
|---|---|---|---|
Haruo Naito
CEO | Chief Executive Officer | 76 | 75-09-30 |
Mitsuru Shomon
DFI | Director of Finance/CFO | - | - |
Makoto Hoketsu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Haruo Naito
CEO | Chief Executive Officer | 76 | 75-09-30 |
Fumihiko Ike
BRD | Director/Board Member | 72 | 21-05-31 |
Toru Moriyama
BRD | Director/Board Member | 69 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 5.78% | 14 M€ | +12.69% | ||
| 1.23% | 240 M€ | +19.42% | ||
| 1.13% | 28,050 M€ | +18.02% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-11 | 6,649 | -3.25% | 2 969 200 |
| 24-06-10 | 6,872 | +1.54% | 893,600 |
| 24-06-07 | 6,768 | -1.66% | 1,146,200 |
| 24-06-06 | 6,882 | -2.80% | 1,641,700 |
| 24-06-05 | 7,080 | +1.65% | 2,006,600 |
Delayed Quote Japan Exchange, June 11, 2024 at 02:00 am EDT
More quotes
Eisai Company specializes in the manufacturing and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical products (87.7%): prescribed drugs, health products, etc.;
- other (12.3%): food additives, chemical products, etc.
Net sales are distributed geographically as follows: Japan (46.2%), Europe (19.5%), Americas (15.5%), China (10.3%) and other (8.4%).
Sector
Pharmaceuticals
Calendar
2024-11-05
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
6,872
JPY
Average target price
8,271
JPY
Spread / Average Target
+20.36%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -5.71% | 12.53B | |
| +46.88% | 779B | |
| +40.61% | 631B | |
| -7.02% | 354B | |
| +19.83% | 333B | |
| +9.84% | 301B | |
| +16.92% | 249B | |
| -1.76% | 216B | |
| +10.70% | 214B | |
| +4.48% | 163B |
- Stock Market
- Equities
- 4523 Stock
